207 related articles for article (PubMed ID: 18588617)
1. Lethal endometrial recurrence after cone biopsy for microinvasive cervical adenocarcinoma.
Singh P; Scurry J; Proietto A
J Obstet Gynaecol Res; 2008 Jun; 34(3):413-7. PubMed ID: 18588617
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
3. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
4. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
5. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
Rooker D; Baalbergen A; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
[TBL] [Abstract][Full Text] [Related]
6. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
[TBL] [Abstract][Full Text] [Related]
7. Endometrial and endocervical curettage findings at the time of cervical conization.
Presley JJ; Hernandez E; Mudafort E; Miyazawa K
J Reprod Med; 1987 Feb; 32(2):99-102. PubMed ID: 3560085
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
Ostör AG; Duncan A; Quinn M; Rome R
Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
[TBL] [Abstract][Full Text] [Related]
9. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma in situ of the uterine cervix: management and outcome.
Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
[TBL] [Abstract][Full Text] [Related]
11. [Status of fractionated abrasion and vaginal endocervical cytology in diagnosis of endometrial cancer].
Schild R; Kutta T
Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):467-70. PubMed ID: 1397942
[TBL] [Abstract][Full Text] [Related]
12. Conservative treatment of microinvasive adenocarcinoma of uterine cervix: long-term follow-up.
Sopracordevole F; Canzonieri V; Giorda G; De Piero G; Lucia E; Campagnutta E
J Low Genit Tract Dis; 2012 Oct; 16(4):381-6. PubMed ID: 22302130
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
14. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
[TBL] [Abstract][Full Text] [Related]
15. Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.
Cohn DE; Morrison CD; Zanagnolo VL; Goist MM; Copeland LJ
Gynecol Oncol; 2005 Jul; 98(1):158-60. PubMed ID: 15913738
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
Maneo A; Chiari S; Bonazzi C; Mangioni C
Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493
[TBL] [Abstract][Full Text] [Related]
17. Comparison between adenocarcinoma in both endocervical and endometrial specimens from fractional curettage and pathologic findings in subsequent hysterectomy specimens.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2008 Sep; 91(9):1313-7. PubMed ID: 18843857
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the diagnosis and treatment of cervical minimal deviation adenocarcinoma].
Li H; Gou HY; Han JS; Li SM; Yang R; Qiao J
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):772-4. PubMed ID: 19173810
[TBL] [Abstract][Full Text] [Related]
19. Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature.
Bisseling KC; Bekkers RL; Rome RM; Quinn MA
Gynecol Oncol; 2007 Dec; 107(3):424-30. PubMed ID: 17707895
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative diagnosis for stage II endometrial carcinoma using endocervical conization].
Fukuda K; Masubuchi S; Masubuchi K
Gan No Rinsho; 1984 Jul; 30(8):933-6. PubMed ID: 6471397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]